Related Experiment Videos
The sensitive period for strabismic amblyopia in humans
M Epelbaum1, C Milleret, P Buisseret
1Service d'Ophtalmologie, Groupe Hospitalier Necker-Enfants Malades, Paris, France.
Ophthalmology
|March 1, 1993
Summary
The sensitive period for treating strabismic amblyopia is before age 3. Early intervention with monocular occlusion yields the best visual acuity recovery in children, with effectiveness diminishing significantly by age 12.
Area of Science:
- Ophthalmology
- Developmental Neuroscience
Background:
- Strabismic amblyopia is a common cause of reduced vision in children.
- Identifying the sensitive period for treatment is crucial for effective intervention.
Purpose of the Study:
- To determine the sensitive period for treating strabismic amblyopia.
- To investigate the age-related susceptibility to monocular occlusion therapy.
Main Methods:
- A cohort of 407 children aged 21 months to 12 years received monocular occlusion treatment.
- Treatment efficacy was quantified by the reduction in amblyopia severity.
Main Results:
- Occlusion therapy was most effective when initiated before 3 years of age.
- Visual acuity recovery decreased with increasing age at treatment onset.
- Treatment showed minimal effectiveness by 12 years of age.
Conclusions:
- The findings suggest a sensitive period for strabismic amblyopia in humans, extending up to approximately age 12.
- Results align with neurophysiological mechanisms of amblyopia observed in animal models.